Page last updated: 2024-10-22

amitriptyline and Biliary Dyskinesia

amitriptyline has been researched along with Biliary Dyskinesia in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Biliary Dyskinesia: A motility disorder characterized by biliary COLIC, absence of GALLSTONES, and an abnormal GALLBLADDER ejection fraction. It is caused by gallbladder dyskinesia and/or SPHINCTER OF ODDI DYSFUNCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Richmond, BK1
Grodman, C1
Walker, J1
Dean, S1
Tiley, EH1
Hamrick, RE1
Statler, K1
Emmett, M1

Trials

1 trial available for amitriptyline and Biliary Dyskinesia

ArticleYear
Pilot Randomized Controlled Trial of Laparoscopic Cholecystectomy vs Active Nonoperative Therapy for the Treatment of Biliary Dyskinesia.
    Journal of the American College of Surgeons, 2016, Volume: 222, Issue:6

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Biliary Dyskinesia; Cholecyste

2016